# Melatonin Shows Promise for Chronic Pain Relief
Researchers have found that melatonin, the hormone best known for regulating sleep, may also reduce chronic pain symptoms. A new study suggests the supplement addresses pain through multiple pathways in the body, offering a potential option for people struggling with persistent discomfort.
Melatonin works beyond its sleep-promoting effects. The compound acts as an antioxidant and anti-inflammatory agent, both factors that contribute to chronic pain conditions. When inflammation and oxidative stress persist in the body, they amplify pain signals. By reducing these underlying mechanisms, melatonin appears to help dial down pain perception itself.
The research examined how melatonin affects various pain conditions. People taking the supplement reported measurable improvements in pain intensity and duration. Results were most pronounced in those dealing with neuropathic pain, fibromyalgia, and musculoskeletal disorders. The anti-inflammatory action seemed to play the largest role in pain reduction.
What sets melatonin apart from traditional pain medications is its safety profile. Unlike opioids or NSAIDs, melatonin carries minimal risk of dependence or gastrointestinal complications. Most people tolerate it well, though some experience drowsiness, particularly at higher doses.
The timing of melatonin use matters. Taking it several hours before bed capitalizes on its natural rhythm in the body. Doses in studies ranged from 3 to 10 milligrams daily, though individual needs vary. Those with sleep disruption related to chronic pain gained dual benefits. Better sleep naturally supports pain recovery, while melatonin's direct anti-inflammatory effects address the pain itself.
Experts caution that melatonin works best as part of a broader pain management strategy. Physical therapy, cognitive behavioral therapy, and stress reduction remain foundational.
